Emirates Approves Lifvendra for Cholesterol
The Emirates Authority for Pharmaceuticals announced the approval of the drug "Lifvandra" for the treatment of high bad cholesterol, making the UAE the second country in the world to approve this medication. The drug aims to lower LDL cholesterol levels and harmful fats, helping reduce the risks of cardiovascular diseases. It is taken orally once daily, and healthy lifestyle practices are recommended alongside consulting a healthcare professional to determine the appropriate treatment. This step reflects the efficiency of the UAE's regulatory system and its commitment to accelerating the access of pharmaceutical innovations to patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)